天康生物 (002100.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.0x

Market Cap

CNY 9.79B

MomentumView details →

1D Return

+0.28%

YTD Return

+14.11%

RSI (14)

78.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.0x

Market Cap

CNY 9.79B

RSI (14)

78.7

MomentumView details →

1D Return

+0.28%

YTD Return

+14.11%

ProfitabilityView details →

Gross Margin

7.97%

Net Margin

−0.60%

EBITDA Margin

5.96%

ROE (TTM)

−1.47%

ROA (TTM)

−0.56%

Asset Turnover

0.94x

GrowthView details →

Revenue YoY

−4.90%

EPS YoY

—

FCF YoY

−42.47%

Revenue CAGR 3Y

−0.02%

EPS CAGR 3Y

−10.61%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.20

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.83x

Current Ratio

1.63x

Quick Ratio

0.82x

Div Yield

0.93%

Div Rate

CNY 0.08

Div Growth 1Y

−64.55%

Financials snapshotView financials →

Revenue (TTM)

16.72B

Net Income (TTM)

−100.79M

Op. CF (TTM)

988.19M

Next earningsNov 3, 2026 →

Latest newsMore news →

Tiankang Biopharmaceutical announced the termination of a non-public offering fundraising project for a pig breeding and fattening base, with remaining funds to be permanently used as working capital.7d ago

Tiankang Biological reported a net loss of 441 million yuan for the first half of 2026, turning from a profit of 338 million yuan in the same period of 2025.9d ago

Similar companies

利安隆300596.SZ 天润工业002283.SZ 佐力药业300181.SZ 豪恩汽电301488.SZ 派林生物000403.SZ 匠心家居301061.SZ Find similar companies →

Latest newsMore news →

Tiankang Biopharmaceutical announced the termination of a non-public offering fundraising project for a pig breeding and fattening base, with remaining funds to be permanently used as working capital.7d ago Tiankang Biological reported a net loss of 441 million yuan for the first half of 2026, turning from a profit of 338 million yuan in the same period of 2025.9d ago